Quidel's Recently Approved Antigen Test For Coronavirus Is 'Game Changer,' Former FDA Chief Says
Quidel Corporation's (NASDAQ: QDEL) development of an antigen test for the novel coronavirus (COVID-19) is a "game changer" in the world's fight against the pandemic, former Food and Drugs Administration commissioner Scott Gottlieb